Compare OVBC & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OVBC | DERM |
|---|---|---|
| Founded | 1872 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 220.0M | 190.3M |
| IPO Year | 1996 | 2021 |
| Metric | OVBC | DERM |
|---|---|---|
| Price | $49.00 | $4.66 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $13.75 |
| AVG Volume (30 Days) | 15.4K | ★ 189.9K |
| Earning Date | 10-27-2026 | 11-16-2026 |
| Dividend Yield | ★ 2.01% | N/A |
| EPS Growth | ★ 42.67 | 34.72 |
| EPS | ★ 1.53 | N/A |
| Revenue | N/A | ★ $61,858,000.00 |
| Revenue This Year | N/A | $25.29 |
| Revenue Next Year | N/A | $50.00 |
| P/E Ratio | $32.68 | ★ N/A |
| Revenue Growth | N/A | ★ 10.20 |
| 52 Week Low | $34.81 | $4.31 |
| 52 Week High | $51.25 | $9.56 |
| Indicator | OVBC | DERM |
|---|---|---|
| Relative Strength Index (RSI) | 68.32 | 38.40 |
| Support Level | $41.55 | $4.79 |
| Resistance Level | $50.69 | $5.50 |
| Average True Range (ATR) | 1.16 | 0.31 |
| MACD | 0.32 | 0.04 |
| Stochastic Oscillator | 77.63 | 29.68 |
Ohio Valley Banc Corporation is a financial holding company. The bank is a full-service financial institution offering a blend of commercial and consumer banking services in Southeastern Ohio and western West Virginia. The banking services offered by the bank include the acceptance of deposits in checking, savings, time and money market accounts; the making and servicing of personal, commercial, and student loans; and the making of construction and real estate loans. It also offers individual retirement accounts, safe deposit boxes, wire transfers, and other standard banking products and services.
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.